Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 4Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1

Interventions

Cyclophosphamide 56fludarabine 30Methotrexate 24blinatumomab 22Dexamethasone 21Cytarabine 21Vincristine 19venetoclax 18Specimen Handling 16fludarabine phosphate 15Whole-Body Irradiation 13Stem Cell Transplantation 12Biopsy 12Tacrolimus 10Mycophenolic Acid 10Daunorubicin 10Thiotepa 9Rituximab 9Prednisone 9Mercaptopurine 9Melphalan 9Immunotherapy, Adoptive 9Magnetic Resonance Spectroscopy 8Doxorubicin 8pegaspargase 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7olverembatinib 6Mesna 6Inotuzumab Ozogamicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Homoharringtonine × Clear all
NCT06855810 2025-08-26

CCCG-TALL-2025

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Recruiting
610 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06742463 2024-12-19

VHAG in Treating R/R T-ALL/LBL

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
50 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡